Claims
- 1. A cDNA containing at least a portion of the Birnavirus genome selected from the group consisting of segment A, segment B and segments A and B, wherein said cDNA includes the 5′ and 3′ terminii of said segments.
- 2. The cDNA according to claim 1, wherein said Birnavirus genome is from Infectious Bursal Disease Virus (IBDV) and cDNA is derived from more than one strain of Birnavirus.
- 3. A recombinant vector comprising at least one copy of a cDNA containing at least a portion of the Birnavirus genome selected from the group consisting of segment A, segment B and segments A and B, wherein said cDNA includes the 5′ and 3′ terminii of said segments.
- 4. A synthetic RNA transcribed from a cDNA containing at least a portion of the Birnavirus genome selected from the group consisting of segment A, segment B and segments A and B, wherein said cDNA includes the 5′ and 3′ terminii of said segments.
- 5. A host cell transformed with the recombinant vector according to claim 3.
- 6. A host cell transformed with a synthetic RNA according to claim 4.
- 7. A live, chimeric Infectious Bursal Disease Virus (IBDV) comprising at least one cDNA of IBDV genome segments A and B, wherein said cDNA is derived from more than one strain of IBDV.
- 8. A vaccine comprising a live, chimeric IBDV according to claim 7.
- 9. A method for producing a live Infectious Bursal Disease Virus (IBDV), comprising the following steps:preparing at least one cDNA of IBDV genome segments A and B, wherein said cDNA is derived from more than one strain of IBDV; initiating synthesis of a dsRNA in a host cell using RNA derived from said cDNA; incubating said host cell in a culture medium; and isolating live, IBDV from said culture medium.
- 10. A synthetic RNA encoding proteins VP1, VP2, VP3, VP4, and VP5 of Infectious Bursal Disease Virus (IBDV), wherein said RNA is derived from more than one strain of IBDV.
- 11. A host cell transfected with the synthetic RNA according to claim 10.
- 12. A cDNA containing at least a portion of the Birnavirus genome selected from the group consisting of segment A, segment B and segments A and B of Birnavirus, wherein said cDNA includes the 5′ and 3′ termini of said segments and said cDNA is derived from more than one strain of Birnavirus.
- 13. A recombinant vector comprising the cDNA according to claim 12.
- 14. The vector according to claim 13, where said vector is a plasmid.
- 15. A host cell transformed with the vector according to claim 14.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of application Ser. No. 09/198,913, filed on Nov. 14, 1998, now abandoned, which is a divisional of Ser. No. 08/708,541, filed on Sep. 5, 1996, now U.S. Pat. No. 5,871,744. The present application is a national stage entry of PCT/US97/12955 filed on Jul. 31, 1997.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/US97/12955 |
|
WO |
00 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO98/09646 |
3/12/1998 |
WO |
A |
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5871744 |
Vakharia et al. |
Feb 1999 |
A |
6274147 |
Vakharia et al. |
Aug 2001 |
B1 |
Non-Patent Literature Citations (6)
Entry |
Snyder et al. Avian Diseases 38:701-707, 1994.* |
Mundt et al. Journal of Virology 71:5647-5651, 1997.* |
Ganga et al, Journal of Virological Method 50:227-236, 1994.* |
Roberts et al. Virology 247:1-6 (1998).* |
Blake et al. Diseases of Aquatic Organisms 45(2): 89-102 (Abstract only cited).* |
Elston. World Journal of Microbiology & Biotechnology 13(4): 393-403 (Abstract only cited). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09/198913 |
Nov 1998 |
US |
Child |
09/147771 |
|
US |